Bill
A 4163
Requires health insurers to provide coverage for biomarker precision medical testing.*
2024-2025 Regular Session
Introduced by Bob Auth and 54 co-sponsors
New Jersey mandates health insurers cover biomarker precision medical tests to personalize treatment selection, effective April 2025.
Approved P.L.2025, c.49.